Ka
Non vérifié

Kairos Pharma, Ltd

Ce que nous écrivons

BiotechnologieIndustrie pharmaceutiqueOncologieSantéScience
04/06/2026
Oncologie
Santé
Médecine - Divers
Science
Biotechnologie
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
1.00
14/05/2026
Événements
Oncologie
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Kairos Pharma Receives GHP Magazine’s Healthcare & Pharmaceutical Award
1.00
08/05/2026
Oncologie
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
1.00
15/04/2026
Événements
Oncologie
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation
1.00
02/03/2026
Marché du travail
Logiciels
Biotechnologie
Industrie pharmaceutique
Oncologie
Santé
Technique
Médecine - Divers
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
1.00
26/02/2026
Marché financier
Oncologie
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
1.00
20/01/2026
Oncologie
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Événements
Kairos Pharma to Present at 3rd Annual DealFlow Discovery Conference
1.00
17/12/2025
Événements
Industrie
Oncologie
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
1.00
20/10/2025
Oncologie
Santé
Science
Industrie pharmaceutique
Biotechnologie
Événements
Industrie
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
1.00
07/10/2025
Santé
Science
Industrie pharmaceutique
Oncologie
Événements
Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0